Effect Modifiers and Risk Factors of Intraocular Inflammation Following Brolucizumab: A Systematic Review and Meta-analysis.

Saved in:
Bibliographic Details
Title: Effect Modifiers and Risk Factors of Intraocular Inflammation Following Brolucizumab: A Systematic Review and Meta-analysis.
Authors: Abu Serhan H; Department of Ophthalmology, Hamad Medical Corporation, Doha, Qatar., Hassan AK; Gavin Herbert Eye Institute, University of California, Irvine, CA, USA., Rifai M; Faculty of Medicine, Menofyia University, Shebin El Kom, Egypt., Elsayed RA; Faculty of Medicine, South Valley University, Qena, Egypt., Djeffal C; Faculty of Medicine, University of Algiers, Algiers, Algeria., Cherif Y; Faculty of Medicine, University of Algiers, Algiers, Algeria., Aboujabal K; Department of Ophthalmology, Hamad Medical Corporation, Doha, Qatar., Awamleh N; School of Medicine, The University of Jordan, Amman, Jordan., Pereira MA; Department of Ophthalmology, Hamad Medical Corporation, Doha, Qatar., Arya S; Department of Ophthalmology, Hamad Medical Corporation, Doha, Qatar., Anter AM; Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA., Elnahry AG; Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.; Department of Ophthalmology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Source: Current eye research [Curr Eye Res] 2025 Mar; Vol. 50 (3), pp. 241-251. Date of Electronic Publication: 2024 Sep 25.
Publication Type: Journal Article; Systematic Review; Meta-Analysis
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8104312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2202 (Electronic) Linking ISSN: 02713683 NLM ISO Abbreviation: Curr Eye Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first